KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.22.

  • Pfizer's Asset Utilization Ratio fell 414.72% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 414.72%. This contributed to the annual value of 0.29 for FY2024, which is 3340.09% down from last year.
  • Latest data reveals that Pfizer reported Asset Utilization Ratio of 0.22 as of Q3 2025, which was down 414.72% from 0.22 recorded in Q2 2025.
  • Over the past 5 years, Pfizer's Asset Utilization Ratio peaked at 0.67 during Q4 2022, and registered a low of 0.11 during Q4 2023.
  • Its 5-year average for Asset Utilization Ratio is 0.31, with a median of 0.22 in 2025.
  • As far as peak fluctuations go, Pfizer's Asset Utilization Ratio tumbled by 8368.08% in 2023, and later soared by 10630.81% in 2024.
  • Over the past 5 years, Pfizer's Asset Utilization Ratio (Quarter) stood at 0.53 in 2021, then rose by 24.52% to 0.67 in 2022, then crashed by 83.65% to 0.11 in 2023, then surged by 94.8% to 0.21 in 2024, then grew by 2.37% to 0.22 in 2025.
  • Its last three reported values are 0.22 in Q3 2025, 0.22 for Q2 2025, and 0.21 during Q1 2025.